by Dr Jill Firth, BHPR President, Consultant Nurse in Rheumatology and Director for Service Improvement at the Pennine Musculoskeletal Partnership Ltd in Oldham.
Over the past 20 years of working as a special ist nurse, I have witnessed first-hand the changing face of care for people with Musculoskeletal conditions (MSK) – particularly Rheumatoid Arthritis – leading to better outcomes for patients.
This can, in part, be attributed to advances in treatment strategies, including biologic therapies, but is also a consequence of better access to care provided by a multi-disciplinary team (MDT) comprising consultant rheumatologists, specialist nurses, physiotherapists, occupational therapists and podiatrists as a core nucleus.…
Read more of this article
by Professor Matthew Cripps, National Director of NHS RightCare
It’s hard to describe a month like the one we’ve just had, which has been characterised by many positive things for our community, but overshadowed by external events. Like me, many of you will feel worried and dismayed at the result of the EU referendum. There is no denying that whatever the practical implications of it – politically, for the NHS, for our respective areas of work – and whatever actually ends up happening at the end of what could well turn out to be a long and winding road, this result casts tremendous uncertainty over the UK, and Europe, in many different ways and for some time to come.… 
y Dr Peter Lanyon, Consultant Rheumatologist, Nottingham University Hospital;
I was asked to write a blog to raise the profile of my MSK work supported by the Long-Term Conditions Team and, through the cryptic labyrinth of various schemes and initiatives, share with you my thoughts on how we can support sustainable, cost-effective transformation whilst still championing the more person-centred approach.
by Sarah Marsh, National Policy Lead, Long Term Conditions, NHS England
by Ali Rivett, Director of Clinical Affairs, BSR